Annexin Pharmaceuticals AB (publ)

Prospectus ID: 21-22752

Document type
Standalone prospectus
Home member state
Sweden
Prospectus type
Standalone Prospectus
Structure
Single document prospectus
Approval / filing date
19 Oct 2021
National document ID
21-22752
Issuer LEI
5493000JP703HGPJEX27
Language(s)
Swedish

ISINs

  • SE0009664154
  • SE0017070899

Passporting

No passporting notifications filed.

Last verified: 2 Nov 2026

Data sourced from the ESMA prospectus register, updated weekly.

Regulatory Q&As

Browse Prospectus Regulation Q&As → Official ESMA interpretations

📋 Track EU financial regulation continuously

Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.

14-day free trial. No credit card required.